LY3300054 is a novel human monoclonal antibody (IgG1, lambda, Fc-null) targeting PD-L1 expressed on tumor cells and tumor-infiltrating immune cells, preventing binding to its T-cell receptors (PD-1 and CD-80). This evidence concerns the gene CD80 and neoplasm.